Homegrown injection-molding company Core Technology Molding Corp. has closed on the property for its own production and headquarters ... Merck, and Eli Lilly. The target for moving is November ...

Pennsylvania St. calls for a new hotel and entertainment venue. (Rendering courtesy of Boxcar ... secured more project commitments from Eli Lilly and Co., bringing the drug giant’s total ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

Citi analyst Geoff Meacham maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday at $785.41. Meacham covers the Healthcare sector ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... Pavlik shared that as the new administration takes over he is optimistic about how the market will play ...

Several other institutional investors and hedge funds have also made changes to their positions in the company. Peterson Financial Group Inc. acquired a new position in Eli Lilly and Company ...

In this article, we are going to take a look at where Eli Lilly And ... is turned into two new shares. This makes each share half the price, but the total value of the company remains the same.

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...